Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will present at...

ICF (NASDAQ:ICFI), a global consulting and technology services provider, today announced its participation at the Baird 2025 Global Consumer, Technology & Services Conference at the...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, president and chief executive officer, is scheduled to participate and host investor meetings at the...

Optimized subcutaneous (SC) administration of BHV-1400 achieved rapid, deep, selective, and sustained lowering of Gd-IgA1, differentiating Biohaven's leading TRAP degrader for IgAN from the...

Kyndryl (NYSE: KD), a leading provider of mission-critical enterprise technology services, today announced that Chief Financial Officer David Wyshner will speak at the Bank of America Global...